About urinary incontinence
Urinary incontinence is any involuntary urine leakage. It may occur as a result of an abnormal function of the lower urinary tract, overactive bladder, or other illnesses. It is estimated that about 50 percent of women suffer from urinary incontinence at some point in their lives. In men, the prevalence is 5 percent, and most cases are related to prostate diseases. The severity depends on the psychological, physical, and social well-being of the affected individuals.
Technavio's analysts forecast the urinary incontinence products market in Europe to grow at a CAGR of 6.38% over the period 2014-2019.
Covered in this report
This report covers the present scenario and growth prospects of the urinary incontinence products market in Europe for the period 2015-2019. To calculate the market size, the report considers the revenue generated from sales of different types of urinary incontinence treatment products.
Technavio's report, the Urinary Incontinence Products Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It also covers the landscape of the urinary incontinence products market in Europe and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key countries
• Germany
• UK
Key vendors
• American Medical Systems
• Attends Healthcare Group
• B.Braun Melsungen
• C. R. Bard
• Coloplast
• Kimberly-Clark
• Paul Hartmann
• Svenska Cellulosa Aktiebolaget
Other prominent vendor
• Boston Scientific
• ConvaTec
• Dynarex
• Ethicon (Johnson & Johnson)
• Hunter Urology
• Medline Industries
• Ontex International
• P&G
• Uroplasty
Market driver
• Increasing in aging population
• For a full, detailed list, view our report
Market challenge
• Economic burden of UUI
• For a full, detailed list, view our report
Market trend
• Advances in technology
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the Key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
1 Executive Summary
2 List of Abbreviations
3 Scope of the Report
3.1 Market overview
3.2 Product offerings
4 Market Research Methodology
4.1 Market research process
4.2 Research methodology
5 Introduction
6 Market Landscape
6.1 Market overview
6.2 Market size and forecast
6.3 Five forces analysis
7 Urinary Incontinence
7.1 Background
7.2 Types of urinary incontinence
07.2.1 Stress incontinence
07.2.2 Urge incontinence
07.2.3 Mixed incontinence
07.2.4 Functional incontinence
07.2.5 Overflow incontinence
7.3 Treatment techniques for urinary incontinence
8 Market Segmentation by Types of Products
9 Adult Diapers Market in Europe
9.1 Market size and forecast
9.2 Segmentation of adult diapers market in Europe by product
9.3 Raw materials used in adult diapers
10 Urinary Catheters Market in Europe
10.1 Market size and forecast
10.2 Segmentation of urinary catheters by product
10.3 Materials of urinary catheters
10.3.1 Comparison of catheter materials
10.3.2 Comparison of catheter coating materials
11 Urinary Slings Market in Europe
11.1 Market Size and Forecast
11.2 Segmentation of urinary slings market in Europe by type
11.2.1 Vaginal Slings
11.2.2 Male slings
12 Urinary Bulking Agents Market in Europe
12.1 Market size and forecast
13 Urinary Incontinence Accessories Market in Europe
13.1 Market size and forecast
13.2 Market Segmentation by application
14 Europe Medical Device Spending and Reimbursement Scenario
14.1.1 Medical device spending in major OECD countries 2013
14.1.2 Reimbursement Scenario
15 Key Leading Countries
15.1 Germany
15.1.1 Market Size and Forecast
15.2 UK
15.2.1 Market Size and Forecast
16 Buying Criteria
17 Market Growth Drivers
18 Drivers and their Impact
19 Market Challenges
20 Impact of Drivers and Challenges
21 Market Trends
22 Trends and their Impact
23 Vendor Landscape
23.1 Competitive Scenario
23.1.1 Key News
23.1.2 Mergers and Acquisitions
23.2 Market Share Analysis 2014
23.3 Other Prominent Vendors
24 Key Vendor Analysis
24.1 American Medical Systems
24.1.1 Key facts
24.1.2 Business overview
24.1.3 Key brands
24.1.4 Therapeutic areas
24.1.5 Geographical segmentation
24.1.6 Business strategy
24.1.7 Recent developments
24.1.8 SWOT analysis
24.2 Attends Healthcare Group
24.2.1 Key facts
24.2.2 Business overview
24.2.3 Key products
24.2.4 Key brands
24.2.5 Distributors by geography
24.2.6 SWOT analysis
24.3 B. Braun Melsungen
24.3.1 Key facts
24.3.2 Business overview
24.3.3 Business segmentation by revenue 2013
24.3.4 Business segmentation by revenue 2012 and 2013
24.3.5 Geographical segmentation by revenue 2013
24.3.6 Business strategy
24.3.7 Recent developments
24.3.8 SWOT analysis
24.4 C. R. Bard
24.4.1 Key facts
24.4.2 Business overview
24.4.3 Product segmentation by revenue 2013
24.4.4 Product segmentation by revenue 2012 and 2013
24.4.5 Geographical segmentation by revenue 2013
24.4.6 Business strategy
24.4.7 Recent developments
24.4.8 SWOT analysis
24.5 Coloplast
24.5.1 Key facts
24.5.2 Business overview
24.5.3 Business segmentation by revenue 2014
24.5.4 Business segmentation by revenue 2013 and 2014
24.5.5 Geographical segmentation by revenue 2014
24.5.6 Business strategy
24.5.7 Key developments
24.5.8 SWOT analysis
24.6 Kimberly-Clark
24.6.1 Key facts
24.6.2 Business overview
24.6.3 Key products
24.6.4 Business segmentation by revenue 2013
24.6.5 Business segmentation by revenue 2012 and 2013
24.6.6 Geographical segmentation by revenue 2013
24.6.7 Business strategy
24.6.8 Key developments
24.6.9 SWOT analysis
24.7 PAUL HARTMANN
24.7.1 Key facts
24.7.2 Business overview
24.7.3 Business segmentation by revenue 2013
24.7.4 Business segmentation by revenue 2012 and 2013
24.7.5 Geographical segmentation by revenue 2013
24.7.6 Business strategy
24.7.7 Recent developments
24.7.8 SWOT analysis
24.8 Svenska Cellulosa Aktiebolaget
24.8.1 Key facts
24.8.2 Business overview
24.8.3 Key products
24.8.4 Personal care product segmentation by revenue 2013
24.8.5 Revenue from personal care products by geography 2013
24.8.6 Business segmentation by revenue 2013
24.8.7 Business segmentation by revenue 2012 and 2013
24.8.8 Geographical segmentation by revenue 2013
24.8.9 Business strategy
24.8.10 Recent developments
24.8.11 SWOT analysis
25 Other Reports in this Series
List Of Exhibits
Exhibit 1: Market research methodology
Exhibit 2: Urinary incontinence products market in Europe 2014-2019 ($ million)
Exhibit 3: Urinary incontinence statistics in Europe 2014
Exhibit 4: Types of urinary incontinence and prevalence 2014
Exhibit 5: Segmentation of urinary incontinence products market by product type
Exhibit 6: Segmentation of urinary incontinence products market in Europe by product type 2014
Exhibit 7: Adult diapers market in Europe 2014-2019 ($ million)
Exhibit 8: Specifications of adult diapers
Exhibit 9: Segmentation of adult diapers market in Europe by Product
Exhibit 10: Segmentation of adult diapers market in Europe by product 2014
Exhibit 11: Raw materials used in adult diapers
Exhibit 12: Urinary catheters market in Europe 2014-2019 ($ million)
Exhibit 13: Segmentation of urinary catheters market in Europe by product
Exhibit 14: Segmentation of urinary catheters market in Europe by product 2014
Exhibit 15: Materials of urinary catheters
Exhibit 16: Catheter coating materials
Exhibit 17: Urinary slings market in Europe 2014-2019 ($ million)
Exhibit 18: Segmentation of urinary slings market in Europe by type
Exhibit 19: Segmentation of urinary slings market in Europe by type 2014
Exhibit 20: Urinary bulking agents market in Europe 2014-2019 ($ million)
Exhibit 21: Urinary incontinence accessories market in Europe 2014-2019 ($ million)
Exhibit 22: Segmentation of urinary incontinence accessories market in Europe by application
Exhibit 23: Segmentation of urinary incontinence products market in Europe by product type 2014-2019 ($ million)
Exhibit 24: Segmentation of urinary incontinence products market in Europe by product type 2014-2019
Exhibit 25: Medical device spending per capita in major OECD countries 2013
Exhibit 26: Urinary incontinence products market in Germany 2014-2019 ($ million)
Exhibit 27: Urinary incontinence products market in UK 2014-2019 ($ million)
Exhibit 28: Percentage of elderly aged above 65 in different regions 2012 and 2050
Exhibit 29: Estimated percentage of elderly population 2012 and 2050
Exhibit 30: Percentage of women with urinary incontinence 2014
Exhibit 31: Percentage of men with urinary incontinence 2014
Exhibit 32: American Medical Systems: Key brands
Exhibit 33: American Medical Systems: Therapeutic areas
Exhibit 34: American Medical Systems: Geographical segmentation
Exhibit 35: Attends Healthcare Group: Key products
Exhibit 36: Attends Healthcare Group: Key brands
Exhibit 37: Attends Healthcare Group: Distributors by geography
Exhibit 38: B. Braun Melsungen: Business segmentation by revenue 2013
Exhibit 39: B. Braun Melsungen: Business segmentation by revenue 2012 and 2013 ($ million)
Exhibit 40: B. Braun Melsungen: Geographical segmentation by revenue 2013
Exhibit 41: C. R. Bard: Product segmentation by revenue 2013
Exhibit 42: C. R. Bard: Product segmentation by revenue 2012 and 2013 ($ million)
Exhibit 43: C. R. Bard: Geographical segmentation by revenue 2013
Exhibit 44: Coloplast: Business segmentation by revenue 2014
Exhibit 45: Coloplast: Business segmentation by revenue 2013 and 2014 ($ million)
Exhibit 46: Coloplast: Geographical segmentation by revenue 2014
Exhibit 47: Kimberly-Clark: Business segmentation by revenue 2013
Exhibit 48: Kimberly-Clark: Business segmentation by revenue 2012 and 2013 ($ billion)
Exhibit 49: Kimberly-Clark: Geographical segmentation by revenue 2013
Exhibit 50: PAUL HARTMANN: Business segmentation by revenue 2013
Exhibit 51: PAUL HARTMANN: Business segmentation by revenue 2012 and 2013 ($ million)
Exhibit 52: PAUL HARTMANN: Geographical segmentation by revenue 2013
Exhibit 53: Svenska Cellulosa Aktiebolaget: Personal care product segmentation by revenue 2013
Exhibit 54: Svenska Cellulosa Aktiebolaget: Revenue from personal care products by geography 2013
Exhibit 55: Svenska Cellulosa Aktiebolaget: Business segmentation by revenue 2013
Exhibit 56: Svenska Cellulosa Aktiebolaget: Business segmentation by revenue 2012 and 2013 ($ million)
Exhibit 57: Svenska Cellulosa Aktiebolaget: Geographical segmentation by revenue 2013
